AbbVie (ABBV) News Today $185.26 -0.22 (-0.12%) Closing price 06/18/2025 03:59 PM EasternExtended Trading$185.46 +0.20 (+0.11%) As of 07:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is AbbVie Down Today?AbbVie Inc. (NYSE: ABBV) shares are trading higher today after a series of positive clinical trial updates for its migraine prevention therapy atogepant (Qulipta®/Aquipta®). Phase III trial success: AbbVie reported that atogepant met its primary endpoint in a pivotal study, demonstrating significant reductions in migraine days versus placebo. Head-to-head superiority: In the Phase 3 TEMPLE study, atogepant showed superior efficacy and tolerability compared with topiramate—fewer discontinuations due to adverse events and all secondary endpoints achieved statistical significance. Multiple independent confirmations: Coverage from Reuters, Yahoo Finance, Benzinga, PharmaExec and others highlighted atogepant’s clear advantage over generic treatments and topiramate in preventing headaches. AbbVie’s “Golden Ticket” collaboration program wrapped up after a year, underscoring the company’s commitment to external innovation but with no immediate revenue implications. Posted 11h agoAI Generated. May Contain Errors. ABBV Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Spirit of America Management Corp NY Trims Stock Position in AbbVie Inc. (NYSE:ABBV)Spirit of America Management Corp NY lowered its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 10.7% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 21,600 shares of the company's stock after selling 2,600 shJune 20 at 6:57 AM | marketbeat.comGood Steward Wealth Advisors LLC Invests $856,000 in AbbVie Inc. (NYSE:ABBV)Good Steward Wealth Advisors LLC acquired a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 4,086 shares of the company's stock, valued at aJune 20 at 6:33 AM | marketbeat.comAvior Wealth Management LLC Sells 3,895 Shares of AbbVie Inc. (NYSE:ABBV)Avior Wealth Management LLC lessened its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 7.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 48,924 shares of the company's stock after selling 3,895 shares during the period. Avior WealtJune 20 at 6:23 AM | marketbeat.comORG Partners LLC Has $852,000 Position in AbbVie Inc. (NYSE:ABBV)ORG Partners LLC cut its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 66.4% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,065 shares of the company's stock after selling 8,031 shares during the quarter. ORG Partners LLC'sJune 20 at 6:23 AM | marketbeat.comRetirement Systems of Alabama Sells 93,782 Shares of AbbVie Inc. (NYSE:ABBV)Retirement Systems of Alabama cut its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 10.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 806,047 shares of the company's stock after sellingJune 20 at 5:48 AM | marketbeat.comUnited Advisor Group LLC Has $611,000 Holdings in AbbVie Inc. (NYSE:ABBV)United Advisor Group LLC decreased its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 34.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,918 shares of the company's stock after sellingJune 20 at 5:22 AM | marketbeat.comWealth Enhancement Advisory Services LLC Grows Stake in AbbVie Inc. (NYSE:ABBV)Wealth Enhancement Advisory Services LLC lifted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 536,450 shares of the company's stJune 20 at 3:47 AM | marketbeat.comAbbVie’s Phase III trial of atogepant for migraine meets primary goalJune 19 at 2:26 PM | finance.yahoo.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Bay Colony Advisory Group Inc d b a Bay Colony AdvisorsBay Colony Advisory Group Inc d b a Bay Colony Advisors cut its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 20.6% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 8,345 shares of the company's stock after selling 2,167 shares during the periJune 19 at 7:41 AM | marketbeat.comORG Wealth Partners LLC Increases Stake in AbbVie Inc. (NYSE:ABBV)ORG Wealth Partners LLC increased its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 54.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 22,823 shares of the company's stock after purchasing an additional 8,015 shares during the period. AbbVJune 19 at 7:23 AM | marketbeat.comEnvestnet Portfolio Solutions Inc. Cuts Holdings in AbbVie Inc. (NYSE:ABBV)Envestnet Portfolio Solutions Inc. cut its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 28.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 142,801 shares of the compJune 19 at 6:53 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Catalina Capital Group LLCCatalina Capital Group LLC trimmed its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 69.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,249 shares of the company's stock after selling 7,421 sJune 19 at 6:53 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Acquired by Sterling Investment Counsel LLCSterling Investment Counsel LLC lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 131.1% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 8,251 shares of the company's stock after acquiring an additional 4,681 shJune 19 at 6:44 AM | marketbeat.comJanney Capital Management LLC Has $21.29 Million Stake in AbbVie Inc. (NYSE:ABBV)Janney Capital Management LLC lowered its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 4.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 101,592 shares of the company's stock after selling 5,160 shareJune 19 at 5:58 AM | marketbeat.comJohnson Investment Counsel Inc. Grows Stock Position in AbbVie Inc. (NYSE:ABBV)Johnson Investment Counsel Inc. boosted its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 3.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 161,824 shares of the company's stock after buying an additionJune 19 at 5:33 AM | marketbeat.comAbbVie's Migraine Drug Achieves Superiority In Preventing Headaches Compared To Generic Treatment In Head To Head TrialJune 18 at 6:23 PM | benzinga.comAbbVie (NYSE:ABBV) Announces Positive Phase 3 Results for Migraine Drug AtogepantJune 18 at 6:23 PM | finance.yahoo.comAbbVie's migraine drug meets main goal in head-to-head study with topiramateJune 18 at 6:23 PM | msn.comAbbVie succeeds in late-stage migraine treatment trialJune 18 at 9:27 AM | seekingalpha.comAbbVie's migraine drug meets main goal of late-stage studyJune 18 at 7:27 AM | reuters.comAbbVie Announces New Data Demonstrating Atogepant (QULIPTA® / AQUIPTA®) Achieves Superiority Across All Endpoints in Phase 3 Head-to-Head Study Compared to Topiramate for Migraine PreventionJune 18 at 7:15 AM | prnewswire.comState of Alaska Department of Revenue Acquires 5,307 Shares of AbbVie Inc. (NYSE:ABBV)State of Alaska Department of Revenue lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 1.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 280,921 shares of the company's stock after purchasing anJune 18 at 7:00 AM | marketbeat.comAnalyst IMS Investment Management Services Ltd. Has $1.17 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV)Analyst IMS Investment Management Services Ltd. increased its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 69.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,594 shaJune 18 at 6:59 AM | marketbeat.comLifeWealth Investments LLC Invests $375,000 in AbbVie Inc. (NYSE:ABBV)LifeWealth Investments LLC bought a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,792 shares of the company's stock, valued at approxiJune 18 at 6:51 AM | marketbeat.comPUREfi Wealth LLC Acquires 1,995 Shares of AbbVie Inc. (NYSE:ABBV)PUREfi Wealth LLC lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 67.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,951 shares of the company's stock after purchasing an additional 1,995 sharJune 18 at 6:29 AM | marketbeat.comKingswood Wealth Advisors LLC Buys 14,174 Shares of AbbVie Inc. (NYSE:ABBV)Kingswood Wealth Advisors LLC increased its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 114.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 26,507 shares of the company's stock after acquiringJune 18 at 6:29 AM | marketbeat.comClarius Group LLC Increases Holdings in AbbVie Inc. (NYSE:ABBV)Clarius Group LLC increased its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 26.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,148 shares of the company's stock after purchasing an additional 4June 18 at 5:32 AM | marketbeat.comCENTRAL TRUST Co Has $48.15 Million Position in AbbVie Inc. (NYSE:ABBV)CENTRAL TRUST Co lowered its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 1.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 229,796 shares of the company's stock after sellinJune 18 at 5:05 AM | marketbeat.comAbbVie says Phase 3 Verona trial of venetoclax/azacitidine did not meet endpointJune 17 at 7:20 PM | finance.yahoo.comAbbVie's Cancer Drug Venetoclax Falls Short In Phase 3 Combination Trial For Myelodysplastic SyndromesJune 17 at 7:20 PM | benzinga.comAbbVie (ABBV) Faces Potential Challenges Amid U.S. Advertising Policy ChangesJune 17 at 12:44 PM | gurufocus.comAbbVie's Diversification Strategy Cushions Venetoclax MDS BlowJune 17 at 7:10 AM | seekingalpha.comPKO Investment Management Joint Stock Co Has $3.35 Million Stock Position in AbbVie Inc. (NYSE:ABBV)PKO Investment Management Joint Stock Co grew its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 18.5% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,000 shares of the company's stock after buying an additional 2,500 sJune 17 at 6:55 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Bfsg LLCBfsg LLC cut its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 22,652 shares of the company's stock after selling 1,414June 17 at 6:34 AM | marketbeat.comLesa Sroufe & Co Acquires New Stake in AbbVie Inc. (NYSE:ABBV)Lesa Sroufe & Co acquired a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 2,599 shares of the company's stock, valued at approximately $54June 17 at 6:34 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Position Reduced by Robertson Stephens Wealth Management LLCRobertson Stephens Wealth Management LLC reduced its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 9.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,841 shares of theJune 17 at 6:24 AM | marketbeat.comNBT Bank N A NY Decreases Stake in AbbVie Inc. (NYSE:ABBV)NBT Bank N A NY trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 2.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 53,232 shares of the company's stock after selling 1,418 shares during the quarter. NBTJune 17 at 6:24 AM | marketbeat.comStrategic Advisors LLC Has $10.55 Million Stake in AbbVie Inc. (NYSE:ABBV)Strategic Advisors LLC decreased its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 2.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,333 shares of the company's stock after sellinJune 17 at 5:56 AM | marketbeat.comChicago Capital LLC Sells 10,500 Shares of AbbVie Inc. (NYSE:ABBV)Chicago Capital LLC trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 19.8% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 42,503 shares of the company's stock after selling 10,500 shares during theJune 17 at 5:56 AM | marketbeat.comPatton Fund Management Inc. Sells 6,536 Shares of AbbVie Inc. (NYSE:ABBV)Patton Fund Management Inc. lessened its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 23.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,930 shares of the company's sJune 17 at 5:47 AM | marketbeat.comConsilium Wealth Advisory LLC Has $442,000 Holdings in AbbVie Inc. (NYSE:ABBV)Consilium Wealth Advisory LLC lessened its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 60.0% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,112 shares of the company's stock after selling 3,163 shares during the quarJune 17 at 5:47 AM | marketbeat.comGrove Bank & Trust Grows Position in AbbVie Inc. (NYSE:ABBV)Grove Bank & Trust increased its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 14.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,037 shares of the company's stock afJune 17 at 4:53 AM | marketbeat.comAbbVie, ADARx Pharmaceuticals Partner to Develop Next-Gen siRNA TherapeuticsJune 17 at 3:54 AM | insidermonkey.comAbbVie (ABBV) Pipeline Bolstered as FDA Approves Mavyret Label Expansion for Hepatitis CJune 17 at 3:54 AM | insidermonkey.comEHA 2025: Genmab and AbbVie’s Epkinly outpaces BiTE rivals in r/r DLBCL trialJune 16, 2025 | finance.yahoo.comAbbVie fails in late-stage trial for Roche-partnered blood cancer therapy venetoclaxJune 16, 2025 | seekingalpha.comAbbVie says blood cancer drug fails late-stage trialJune 16, 2025 | reuters.comAbbVie's venetoclax fails in phase 3 trial for MDS treatmentJune 16, 2025 | investing.comAbbVie Provides Update on VERONA Trial for Newly Diagnosed Higher-Risk Myelodysplastic SyndromesJune 16, 2025 | prnewswire.comMason & Associates Inc Sells 1,531 Shares of AbbVie Inc. (NYSE:ABBV)Mason & Associates Inc cut its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 34.0% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,975 shares of the company's stock after selling 1,531 shares duringJune 16, 2025 | marketbeat.com Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address ABBV Media Mentions By Week ABBV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABBV News Sentiment▼1.150.69▲Average Medical News Sentiment ABBV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABBV Articles This Week▼9358▲ABBV Articles Average Week Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LLY News Today JNJ News Today MRK News Today PFE News Today BMY News Today ZTS News Today RPRX News Today CORT News Today JAZZ News Today PRGO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABBV) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ABBV Stock Free ABBV Stock Alerts